Schalk, Gerwin https://orcid.org/0000-0003-3443-9487
Brunner, Peter https://orcid.org/0000-0002-2588-2754
Allison, Brendan Z.
Soekadar, Surjo R.
Guan, Cuntai https://orcid.org/0000-0002-0872-3276
Denison, Tim
Rickert, Jörn
Miller, Kai J.
Article History
Accepted: 5 April 2024
First Online: 31 May 2024
Competing interests
: G.S. previously consulted for CorTec and currently consults for NeuroXess. T.D. is a director and shareholder at Amber Therapeutics, and consults for CorTec. He has previously consulted for Synchron, Inspire and Galvani. J.R. previously served as CEO for CorTec and is a shareholder at CorTec and Neudio. The other authors report no competing interests.